I think it comes down to this: How much could a novice rely on this diagnostic tool to guide the treatment, and whats the worst that could happen if it was wrong?
Its simply not the silver bullet that some were claiming where experienced doctors would be made redundant.
So then you have to ask, what is its role in the real world and its commercial appeal?
- Forums
- ASX - By Stock
- RAP
- Ann: Positive Preliminary Results from SMARTCOUGH-C-2 Study
Ann: Positive Preliminary Results from SMARTCOUGH-C-2 Study, page-98
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
- There are more pages in this discussion • 272 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAP (ASX) to my watchlist
The Watchlist
SBW
SHEKEL BRAINWEIGH LTD
Dani Nadri, Country Manager Australia
Dani Nadri
Country Manager Australia
SPONSORED BY The Market Online